Arfolitixorin
- a drug candidate
for colorectal cancer

Read more

More than 365 000 CRC patients
could be treated with arfolitixorin

Read more

Pivotal Study ISO-CC-007

Successful End-of-Phase 2
meeting with FDA and
Phase 3 Program for
arfolitixorin agreed

Read More

Previous

Next

Startpage 2

Upcoming Events